Literature DB >> 18790182

Hepatic stellate cell activation and hepatic fibrosis induced by ischemia/reperfusion injury.

F Cheng1, Y Li, L Feng, S Li.   

Abstract

OBJECTIVE: Warm ischemia causes severe allograft damage in liver transplantation. However, the long-term effects of ischemia/reperfusion injury (IRI) on fibrosis have not been fully elucidated. In this study, we used a partial warm hepatic ischemia mouse model to monitor fibrosis in the ischemic liver.
MATERIALS AND METHODS: Male BALB/c mice were divided into ischemic and sham groups (n = 30/group). Via a midline laparotomy, an atraumatic clip was used to interrupt the arterial and the portal venous blood supply to the left liver lobe. After 90 minutes of partial hepatic ischemia, the clip was removed initiating hepatic reperfusion. Samples from normal, sham, and ischemic liver tissues were collected at intervals of 1, 5, 10, 15, 20, or 30 days after operation (n = 5 for each time point) for hematoxylin-eosin (H&E), Mallory's trichrome, and alpha-smooth muscle actin (alpha-SMA) immunohistochemical stains for fibrosis and activation of hepatic stellate cell (HSCs).
RESULTS: IRI caused significant HSC activation in the ischemic liver tissues. Mallory's trichrome stain demonstrated that IRI caused hepatic parenchymal fibrosis near portal tracts and central veins. With prolonged reperfusion time hepatic parenchymal fibrosis was aggravated, showing the same pattern of HSC activation. IRI also caused increased portal tract fibrosis in ischemic liver tissues, especially around biliary tracts.
CONCLUSIONS: Hepatic IRI caused HSC activation, increasing hepatic parenchymal and portal tract fibrosis in ischemic liver tissues.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18790182     DOI: 10.1016/j.transproceed.2008.06.052

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  10 in total

1.  Selective expansion of allogeneic regulatory T cells by hepatic stellate cells: role of endotoxin and implications for allograft tolerance.

Authors:  Anil Dangi; Tina L Sumpter; Shoko Kimura; Donna B Stolz; Noriko Murase; Giorgio Raimondi; Yoram Vodovotz; Chao Huang; Angus W Thomson; Chandrashekhar R Gandhi
Journal:  J Immunol       Date:  2012-03-16       Impact factor: 5.422

Review 2.  miR-21 in ischemia/reperfusion injury: a double-edged sword?

Authors:  Xialian Xu; Alison J Kriegel; Xiaoyan Jiao; Hong Liu; Xiaowen Bai; Jessica Olson; Mingyu Liang; Xiaoqiang Ding
Journal:  Physiol Genomics       Date:  2014-08-26       Impact factor: 3.107

Review 3.  Ischaemia reperfusion injury in liver transplantation: Cellular and molecular mechanisms.

Authors:  Wasim A Dar; Elise Sullivan; John S Bynon; Holger Eltzschig; Cynthia Ju
Journal:  Liver Int       Date:  2019-04-02       Impact factor: 5.828

4.  Fra-2 mediates oxygen-sensitive induction of transforming growth factor beta in cardiac fibroblasts.

Authors:  Sashwati Roy; Savita Khanna; Ali Azad; Rebecca Schnitt; Guanglong He; Cora Weigert; Hidenori Ichijo; Chandan K Sen
Journal:  Cardiovasc Res       Date:  2010-04-28       Impact factor: 10.787

5.  Hepatic stellate cells undermine the allostimulatory function of liver myeloid dendritic cells via STAT3-dependent induction of IDO.

Authors:  Tina L Sumpter; Anil Dangi; Benjamin M Matta; Chao Huang; Donna B Stolz; Yoram Vodovotz; Angus W Thomson; Chandrashekhar R Gandhi
Journal:  J Immunol       Date:  2012-09-07       Impact factor: 5.422

6.  Hepatic stellate cells preferentially induce Foxp3+ regulatory T cells by production of retinoic acid.

Authors:  Richard M Dunham; Manoj Thapa; Victoria M Velazquez; Elizabeth J Elrod; Timothy L Denning; Bali Pulendran; Arash Grakoui
Journal:  J Immunol       Date:  2013-01-28       Impact factor: 5.422

7.  Attenuation of early liver fibrosis by herbal compound "Diwu Yanggan" through modulating the balance between epithelial-to-mesenchymal transition and mesenchymal-to-epithelial transition.

Authors:  Xin Shen; Sisi Cheng; Yu Peng; Hongli Song; Hanmin Li
Journal:  BMC Complement Altern Med       Date:  2014-10-27       Impact factor: 3.659

Review 8.  Role of hepatic stellate cells in liver ischemia-reperfusion injury.

Authors:  Yuming Peng; Qiang Yin; Miaoxian Yuan; Lijian Chen; Xinyi Shen; Weixin Xie; Jinqiao Liu
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

9.  Meta-analysis of the clinical value of danshen injection and huangqi injection in liver cirrhosis.

Authors:  Changtai Zhu; Hao Cao; Xifa Zhou; Chunlei Dong; Judong Luo; Changsong Zhang; Jinming Liu; Yang Ling
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-28       Impact factor: 2.629

Review 10.  Ischemia reperfusion-facilitated sinusoidal endothelial cell injury in liver transplantation and the resulting impact of extravasated platelet aggregation.

Authors:  T Miyashita; S Nakanuma; A K Ahmed; I Makino; H Hayashi; K Oyama; H Nakagawara; H Tajima; H Takamura; I Ninomiya; S Fushida; J W Harmon; T Ohta
Journal:  Eur Surg       Date:  2015-10-14       Impact factor: 0.953

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.